Home6185 • HKG
add
Cansino Biologics Inc
Previous close
$21.50
Day range
$21.05 - $21.85
Year range
$14.80 - $34.65
Market cap
9.44B HKD
Avg Volume
1.40M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 114.28M | 13.65% |
Operating expense | 181.02M | -26.12% |
Net income | -170.10M | -21.89% |
Net profit margin | -148.84 | -7.25% |
Earnings per share | — | — |
EBITDA | -52.88M | 67.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.01B | -25.38% |
Total assets | 8.57B | -23.60% |
Total liabilities | 3.46B | -16.32% |
Total equity | 5.11B | — |
Shares outstanding | 247.04M | — |
Price to book | 1.04 | — |
Return on assets | -3.16% | — |
Return on capital | -3.64% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -170.10M | -21.89% |
Cash from operations | -108.20M | 68.68% |
Cash from investing | 275.01M | 259.88% |
Cash from financing | 147.37M | 1,506.94% |
Net change in cash | 328.81M | 160.07% |
Free cash flow | -452.77M | 25.56% |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,494